The Prostate Health Index (PHI) was approved by the Food and Drug Administration (FDA) in June 2012 for the detection of PCa in men aged 50 or older, with a PSA between 4 and 10 μg/L and a non-suspicious digital rectal examination (DRE). Here, KLK3 is linked to posterior cortical atrophy.